Business
Press Release Mar 21 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 21, 2023, titled "Zydus receives final and tentative Approval from the USFDA for Tofacitinib Tablets, 5 mg and 10 mg, respectively".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 21, 2023, titled \"Zydus receives final and tentative Approval from the USFDA for Tofacitinib Tablets, 5 mg and 10 mg, respectively\". View Attachment","length":377,"tagName":"div"}]